Video yükleniyor...

Video Yüklenemedi

Bu video yüklenirken bir sorun oluştu. Bu geçici bir ağ sorunundan kaynaklanıyor olabilir veya video kullanılamıyor olabilir.

Ana Sayfaya Dön

Mel Gibson isn't lying... A recent study documented COMPLETE REMISSION of Stage IV cancers using fenbendazole. Patients with advanced melanoma, breast, and prostate cancer saw their tumors disappear — without chemotherapy. Clinical trials must be launched immediately.

Nicolas Hulscher, MPH

272,093 subscribers

1,959,841 görüntüleme • 5 ay önce •via X (Twitter)

Sağlık & İyilik Haberler & Politika Bilim & Teknoloji

Anya Rossi• Live Now

Private livecam show

0 Yorum

Yorum bulunmuyor

Orijinal gönderinin yorumları burada görünecek

Benzer Videolar

"NEW STUDY: Fenbendazole Linked to Remission or Near-Remission in Three Stage IV Cancer Patients Breast, prostate, and melanoma patients experienced dramatic tumor regression and long-lasting remission — without chemotherapy." Nicolas Hulscher MPH Nicolas Hulscher, MPH McCullough Foundation Peter A. McCullough, MD, MPH® full article below

"NEW STUDY: Fenbendazole Linked to Remission or Near-Remission in Three Stage IV Cancer Patients Breast, prostate, and melanoma patients experienced dramatic tumor regression and long-lasting remission — without chemotherapy." Nicolas Hulscher MPH Nicolas Hulscher, MPH McCullough Foundation Peter A. McCullough, MD, MPH® full article below

DoctorRay

17,466 görüntüleme • 11 ay önce

Mel Gibson wasn’t lying when he said three of his friends’ Stage IV cancers disappeared after taking ivermectin… Our study found 84% of cancer patients taking ivermectin declared COMPLETE REMISSION, TUMOR SHRINKAGE, or HALTED CANCER GROWTH.

Mel Gibson wasn’t lying when he said three of his friends’ Stage IV cancers disappeared after taking ivermectin… Our study found 84% of cancer patients taking ivermectin declared COMPLETE REMISSION, TUMOR SHRINKAGE, or HALTED CANCER GROWTH.

Nicolas Hulscher, MPH

42,953 görüntüleme • 25 gün önce

The LARGEST systematic review study ever conducted on ivermectin use in cancer patients identified 14 distinct anticancer mechanisms across 12 cancer types and found no safety concerns. Meanwhile, a recent study reported COMPLETE REMISSION of Stage IV cancers with fenbendazole.

The LARGEST systematic review study ever conducted on ivermectin use in cancer patients identified 14 distinct anticancer mechanisms across 12 cancer types and found no safety concerns. Meanwhile, a recent study reported COMPLETE REMISSION of Stage IV cancers with fenbendazole.

Nicolas Hulscher, MPH

90,205 görüntüleme • 6 ay önce

Mel Gibson isn't lying... our new study found 84% of cancer patients taking ivermectin + mebendazole declared either COMPLETE REMISSION, TUMOR SHRINKAGE, or HALTED TUMOR GROWTH after 6 months.

Mel Gibson isn't lying... our new study found 84% of cancer patients taking ivermectin + mebendazole declared either COMPLETE REMISSION, TUMOR SHRINKAGE, or HALTED TUMOR GROWTH after 6 months.

Nicolas Hulscher, MPH

1,959,789 görüntüleme • 3 ay önce

STUDY: High-dose IV vitamin C linked to LONG-TERM REMISSION in three advanced cancer patients who declined chemotherapy. Metastatic kidney cancer: lung tumors DISAPPEARED; remission lasted more than 4 YEARS. Muscle-invasive bladder cancer: no recurrence or spread 9 YEARS later. Stage III aggressive lymphoma: no signs of cancer 10 YEARS later. NIH pathologists independently confirmed all 3 diagnoses.

STUDY: High-dose IV vitamin C linked to LONG-TERM REMISSION in three advanced cancer patients who declined chemotherapy. Metastatic kidney cancer: lung tumors DISAPPEARED; remission lasted more than 4 YEARS. Muscle-invasive bladder cancer: no recurrence or spread 9 YEARS later. Stage III aggressive lymphoma: no signs of cancer 10 YEARS later. NIH pathologists independently confirmed all 3 diagnoses.

Nicolas Hulscher, MPH

59,745 görüntüleme • 20 gün önce

🚨COMPLETE REMISSIONS of Stage IV cancers using anti-parasitics are now being documented in the peer-reviewed literature. HUNDREDS of studies find ivermectin and fenbendazole exert over 12 distinct anti-cancer mechanisms across more than 12 cancer types.

🚨COMPLETE REMISSIONS of Stage IV cancers using anti-parasitics are now being documented in the peer-reviewed literature. HUNDREDS of studies find ivermectin and fenbendazole exert over 12 distinct anti-cancer mechanisms across more than 12 cancer types.

Nicolas Hulscher, MPH

5,204,473 görüntüleme • 5 ay önce

🚨The CIA buried knowledge of the anti-cancer effects of anti-parasitics for over 50 YEARS. We now know that ivermectin exerts over 12 distinct anti-cancer mechanisms across 12 cancer types — while COMPLETE REMISSION of Stage IV cancers using fenbendazole has been documented. This vital line of cancer research was set back more than HALF A CENTURY — and millions of cancer victims have paid the price.

🚨The CIA buried knowledge of the anti-cancer effects of anti-parasitics for over 50 YEARS. We now know that ivermectin exerts over 12 distinct anti-cancer mechanisms across 12 cancer types — while COMPLETE REMISSION of Stage IV cancers using fenbendazole has been documented. This vital line of cancer research was set back more than HALF A CENTURY — and millions of cancer victims have paid the price.

Nicolas Hulscher, MPH

22,556 görüntüleme • 5 ay önce

197 Cancer Patients. 84% Reported Clinical Benefit. The Results Are In — And They're Encouraging. Prostate. Breast. Lung. Solid organ cancers across the board — nearly 200 patients tracked for six months on off-label ivermectin and mebendazole. About half saw cancer disappear or regress. A third held stable. The study is conditionally accepted in a peer-reviewed journal. Large-scale randomized trials are the next step. The data says start them now. Join the Fight: Courtesy of The Amber May Show Catch the full episode: #MedicalFreedom

197 Cancer Patients. 84% Reported Clinical Benefit. The Results Are In — And They're Encouraging. Prostate. Breast. Lung. Solid organ cancers across the board — nearly 200 patients tracked for six months on off-label ivermectin and mebendazole. About half saw cancer disappear or regress. A third held stable. The study is conditionally accepted in a peer-reviewed journal. Large-scale randomized trials are the next step. The data says start them now. Join the Fight: Courtesy of The Amber May Show Catch the full episode: #MedicalFreedom

McCullough Foundation

18,043 görüntüleme • 3 ay önce

Fenbendazole: The Future of Cancer Treatment When chemotherapy fails, Fenbendazole has helped some terminal cancer patients reach complete remission. It's affordable, low-risk, and well-tolerated—but Big Pharma ignores it because it can’t be patented. Imagine cancer cells as a factory. Fenbendazole cuts the power and breaks the conveyor belts, halting the cancer’s growth machinery. Meanwhile, healthy cells continue functioning normally—unlike chemo, which harms everything in its path. That’s why Fenbendazole is gaining attention: it targets cancer precisely, without the collateral damage.

Fenbendazole: The Future of Cancer Treatment When chemotherapy fails, Fenbendazole has helped some terminal cancer patients reach complete remission. It's affordable, low-risk, and well-tolerated—but Big Pharma ignores it because it can’t be patented. Imagine cancer cells as a factory. Fenbendazole cuts the power and breaks the conveyor belts, halting the cancer’s growth machinery. Meanwhile, healthy cells continue functioning normally—unlike chemo, which harms everything in its path. That’s why Fenbendazole is gaining attention: it targets cancer precisely, without the collateral damage.

Commentary | Global Ivermectin Research Hub

20,369 görüntüleme • 1 yıl önce

🧬Fenbendazole: The Future of Cancer Treatment When chemotherapy fails, Fenbendazole has reportedly helped some terminal cancer patients achieve complete remission. It is affordable, low-risk, and well-tolerated—but large pharmaceutical companies often overlook it because it cannot be patented. Imagine cancer cells as a factory. Fenbendazole cuts the power and breaks the conveyor belts, halting the machinery that drives cancer growth. Meanwhile, healthy cells continue functioning normally—unlike chemotherapy, which can harm both healthy and cancerous cells. That’s why Fenbendazole is gaining attention: it may target cancer more precisely, without the same level of collateral damage. Follow Dr. Zakaria MD . He is a great oncologist.

🧬Fenbendazole: The Future of Cancer Treatment When chemotherapy fails, Fenbendazole has reportedly helped some terminal cancer patients achieve complete remission. It is affordable, low-risk, and well-tolerated—but large pharmaceutical companies often overlook it because it cannot be patented. Imagine cancer cells as a factory. Fenbendazole cuts the power and breaks the conveyor belts, halting the machinery that drives cancer growth. Meanwhile, healthy cells continue functioning normally—unlike chemotherapy, which can harm both healthy and cancerous cells. That’s why Fenbendazole is gaining attention: it may target cancer more precisely, without the same level of collateral damage. Follow Dr. Zakaria MD . He is a great oncologist.

Joe Tippens

32,080 görüntüleme • 4 ay önce

Pre-clinical trials of a #cancer-#vaccine in #Russia show it's capable of dissolving #melanoma AND #metastasis. It could also work in advanced stage of cancer when combined with other boosters. See my talk with RT for details, followed RT-interview with Director of Gamaleya Research Institute of Epidemiology and Microbiology, Professor Alexander Gintsburg ⬇️

Pre-clinical trials of a #cancer-#vaccine in #Russia show it's capable of dissolving #melanoma AND #metastasis. It could also work in advanced stage of cancer when combined with other boosters. See my talk with RT for details, followed RT-interview with Director of Gamaleya Research Institute of Epidemiology and Microbiology, Professor Alexander Gintsburg ⬇️

Prof. Med dr Marcello Ferrada de Noli #HR4All

81,626 görüntüleme • 1 yıl önce

🚨 IT’S OFFICIAL: Epidemiologist Nicolas Hulscher Says IVERMECTIN and FENBENDAZOL Are Showing Documented Stage IV Cancer Remissions — Big Pharma Cannot Ignore This Anymore | VIDEO 🚨 A global medical firestorm is erupting after epidemiologist Nicolas Hulscher highlighted scientific reports documenting stage IV cancer remissions involving #ivermectin and #fenbendazole , reigniting worldwide debate over Big Pharma, alternative therapies, and the future of cancer treatment. 🚨 THE STAGE IV REMISSION CASES NOW SHOCKING THE MEDICAL WORLD FOLLOW ME, THE NEXT DROP WILL BE SHOCKING.

🚨 IT’S OFFICIAL: Epidemiologist Nicolas Hulscher Says IVERMECTIN and FENBENDAZOL Are Showing Documented Stage IV Cancer Remissions — Big Pharma Cannot Ignore This Anymore | VIDEO 🚨 A global medical firestorm is erupting after epidemiologist Nicolas Hulscher highlighted scientific reports documenting stage IV cancer remissions involving #ivermectin and #fenbendazole , reigniting worldwide debate over Big Pharma, alternative therapies, and the future of cancer treatment. 🚨 THE STAGE IV REMISSION CASES NOW SHOCKING THE MEDICAL WORLD FOLLOW ME, THE NEXT DROP WILL BE SHOCKING.

Dr Charlie Ward Show

34,394 görüntüleme • 1 ay önce

🚨Multiple Studies Confirm Ivermectin, Fenbendazole, & Mushrooms Exhibit Potent Anti-Cancer Activity via 20+ Mechanisms 💠Ivermectin: ✅ Proven safe—even with chemo ✅ Widespread anecdotal reports of remission ✅ 14 distinct anticancer mechanisms (systematic review) ✅ Targets glioblastoma, leukemia, ovarian, cervical cancers & more 💠Fenbendazole: ✅ Linked to remission of Stage IV cancers (Makis et al) ✅ Strong safety profile in humans ✅ Disrupts tumor metabolism & growth pathways 💠Medicinal Mushrooms (Cordyceps, Turkey Tail, Reishi): ✅ Boost NK & T cells ✅ Block angiogenesis ✅ Trigger apoptosis ✅ ↓ cancer risk by 34% (meta-analysis) ✅ ↑ survival & QoL (39 clinical trials) It’s time for cancer therapies that HEAL the body—not destroy it.

Nicolas Hulscher, MPH

199,099 görüntüleme • 11 ay önce

🚨 THIS WAS NEVER SUPPOSED TO BE A CANCER DRUG Fenbendazole was developed to treat parasites. Not cancer. Which is why researchers were surprised enough to publish a case series describing three patients whose cancers reportedly went into remission after using it. Cancer survives by dividing over and over again. Fenbendazole appears to interfere with microtubules, structures cells need to complete that process. The paper doesn't claim fenbendazole is a cure. But it does explain why this decades-old antiparasitic keeps showing up in cancer discussions around the world. And once people start reading the studies for themselves, the next question usually isn't "Does this exist?" It's "Where can I get it?" That's why thousands turn to PharmacyinUSA for fenbendazole, ivermectin, and other repurposed medicines.

🚨 THIS WAS NEVER SUPPOSED TO BE A CANCER DRUG Fenbendazole was developed to treat parasites. Not cancer. Which is why researchers were surprised enough to publish a case series describing three patients whose cancers reportedly went into remission after using it. Cancer survives by dividing over and over again. Fenbendazole appears to interfere with microtubules, structures cells need to complete that process. The paper doesn't claim fenbendazole is a cure. But it does explain why this decades-old antiparasitic keeps showing up in cancer discussions around the world. And once people start reading the studies for themselves, the next question usually isn't "Does this exist?" It's "Where can I get it?" That's why thousands turn to PharmacyinUSA for fenbendazole, ivermectin, and other repurposed medicines.

PharmacyinUSA

14,784 görüntüleme • 1 ay önce

100% Cancer Remission Achieved in ALL Patients of Groundbreaking Study Dr. Andrea Cercek, one of the lead researchers, said: “It’s absolutely incredible ... We’ve certainly never seen this before.” All 12 patients experienced complete rectal cancer remission after receiving dostarlimab, a monoclonal antibody. This particular monoclonal antibody achieved 100% cancer remission without chemotherapy, radiation, surgery, or the toxic side effects that come with such therapies. The authors wrote: “All 12 patients (100%; 95% confidence interval) had a clinical complete response, with no evidence of tumor on magnetic resonance imaging ... and no cases of progression or recurrence had been reported during follow-up (range, 6 to 25 months after treatment). No adverse events of grade 3 or higher have been reported.” How does this monoclonal antibody actually work? Dr. Andrea Cercek explained that it essentially unlocks the body’s ability to heal itself.

100% Cancer Remission Achieved in ALL Patients of Groundbreaking Study Dr. Andrea Cercek, one of the lead researchers, said: “It’s absolutely incredible ... We’ve certainly never seen this before.” All 12 patients experienced complete rectal cancer remission after receiving dostarlimab, a monoclonal antibody. This particular monoclonal antibody achieved 100% cancer remission without chemotherapy, radiation, surgery, or the toxic side effects that come with such therapies. The authors wrote: “All 12 patients (100%; 95% confidence interval) had a clinical complete response, with no evidence of tumor on magnetic resonance imaging ... and no cases of progression or recurrence had been reported during follow-up (range, 6 to 25 months after treatment). No adverse events of grade 3 or higher have been reported.” How does this monoclonal antibody actually work? Dr. Andrea Cercek explained that it essentially unlocks the body’s ability to heal itself.

The Vigilant Fox 🦊

2,527,788 görüntüleme • 2 yıl önce

100% Cancer Remission Achieved in ALL Patients in Groundbreaking Study Dr. Andrea Cercek, one of the lead researchers, said: “It’s absolutely incredible ... We’ve certainly never seen this before.” All 12 patients experienced complete rectal cancer remission after receiving dostarlimab, a monoclonal antibody. This particular monoclonal antibody achieved 100% cancer remission without chemotherapy, radiation, surgery, or the toxic side effects that come with such therapies. The authors wrote: “All 12 patients (100%; 95% confidence interval) had a clinical complete response, with no evidence of tumor on magnetic resonance imaging ... and no cases of progression or recurrence had been reported during follow-up (range, 6 to 25 months after treatment). No adverse events of grade 3 or higher have been reported.” How does this monoclonal antibody actually work? Dr. Cercek explained that it essentially unlocks the body’s ability to heal itself.

100% Cancer Remission Achieved in ALL Patients in Groundbreaking Study Dr. Andrea Cercek, one of the lead researchers, said: “It’s absolutely incredible ... We’ve certainly never seen this before.” All 12 patients experienced complete rectal cancer remission after receiving dostarlimab, a monoclonal antibody. This particular monoclonal antibody achieved 100% cancer remission without chemotherapy, radiation, surgery, or the toxic side effects that come with such therapies. The authors wrote: “All 12 patients (100%; 95% confidence interval) had a clinical complete response, with no evidence of tumor on magnetic resonance imaging ... and no cases of progression or recurrence had been reported during follow-up (range, 6 to 25 months after treatment). No adverse events of grade 3 or higher have been reported.” How does this monoclonal antibody actually work? Dr. Cercek explained that it essentially unlocks the body’s ability to heal itself.

The Vigilant Fox 🦊

1,600,442 görüntüleme • 2 yıl önce

Great to see Dr Joe Ladapo and Dr William Makis collaborating on the use of ivermectin/fenbendezole in cancer treatment. Studies that verify the astonishing findings of Dr Makis. Who is treating over 6000 patients with great success in early stages of cancer. Achieving remission or significant shrinkage in tumours. Even having some success with stage 4 cancers. The Fenbendazole study showing patients going from stage 4 to cancer free and remained so up to 3 years. ‘That’s why the research is so important so that we can prove these things that I’m seeing in my clinic.’

Great to see Dr Joe Ladapo and Dr William Makis collaborating on the use of ivermectin/fenbendezole in cancer treatment. Studies that verify the astonishing findings of Dr Makis. Who is treating over 6000 patients with great success in early stages of cancer. Achieving remission or significant shrinkage in tumours. Even having some success with stage 4 cancers. The Fenbendazole study showing patients going from stage 4 to cancer free and remained so up to 3 years. ‘That’s why the research is so important so that we can prove these things that I’m seeing in my clinic.’

Kat A 🌸

39,866 görüntüleme • 10 ay önce

Reminder - Pfizer and Moderna COVID-19 mRNA Vaccines cause Turbo Cancer Top 5: Lymphoma, Brain, Breast, Colon, Lung Concerns have been raised about a disturbing trend observed in clinical practice. Patients who have been cancer-free for years are experiencing sudden, aggressive relapses with rapidly growing tumors shortly after receiving COVID-19 vaccine booster doses. These cases, described as "turbo cancers," exhibit unprecedented characteristics: explosive tumor growth, advanced-stage presentation at diagnosis, and involvement of multiple organs. Affected cancers include pancreatic, ovarian, lung, and colorectal, with colorectal cases showing particularly alarming growth patterns. Uniquely, some patients present with multiple distinct cancers within a single organ, a phenomenon rarely seen before. Notable cases include colorectal cancers with two genetically distinct tumors in the large intestine and a woman with breast cancer harboring three different tumors across both breasts. Blood cancers, such as lymphomas and leukemias, are also emerging rapidly post-vaccination. These trends are being observed globally in regions where mRNA vaccines have been widely administered. Public health authorities have been reluctant to investigate or acknowledge a potential correlation, despite the striking temporal association and the unprecedented nature of these aggressive cancers. This issue demands immediate attention, rigorous research, and transparent discussion to address the implications for patient care and public health.

Reminder - Pfizer and Moderna COVID-19 mRNA Vaccines cause Turbo Cancer Top 5: Lymphoma, Brain, Breast, Colon, Lung Concerns have been raised about a disturbing trend observed in clinical practice. Patients who have been cancer-free for years are experiencing sudden, aggressive relapses with rapidly growing tumors shortly after receiving COVID-19 vaccine booster doses. These cases, described as "turbo cancers," exhibit unprecedented characteristics: explosive tumor growth, advanced-stage presentation at diagnosis, and involvement of multiple organs. Affected cancers include pancreatic, ovarian, lung, and colorectal, with colorectal cases showing particularly alarming growth patterns. Uniquely, some patients present with multiple distinct cancers within a single organ, a phenomenon rarely seen before. Notable cases include colorectal cancers with two genetically distinct tumors in the large intestine and a woman with breast cancer harboring three different tumors across both breasts. Blood cancers, such as lymphomas and leukemias, are also emerging rapidly post-vaccination. These trends are being observed globally in regions where mRNA vaccines have been widely administered. Public health authorities have been reluctant to investigate or acknowledge a potential correlation, despite the striking temporal association and the unprecedented nature of these aggressive cancers. This issue demands immediate attention, rigorous research, and transparent discussion to address the implications for patient care and public health.

Camus

112,291 görüntüleme • 1 yıl önce